Online   |     |   Public conference

From lab to patients: How to make the way Europe regulates medicines future-proof?

Online public session, 9 February 2022, 11:30 – 12:00 CET / REPLAY NOW AVAILABLE

An interactive panel on how the historical rewrite of the EU pharma legislation and the new EU pharmaceutical strategy can embrace latest digital and medical scientific developments, and why we need a more innovative, fast and flexible regulatory framework.

Among the topics to be discussed:

  • Which medical and digital technologies have the highest potential to transform healthcare in the next 10-20 years?  
  • What will it take for Europe to become a true world leader in health and life science and innovation?
  • Can Europe make the best use of real-world data and evidence in medicinal product development?
  • How can Europe’s regulatory approach allow ground-breaking R&D and future technologies to flourish?

This session, organised in the context of the Science|Business Horizon Europe: The first assessment conference, features the launch of the new Future-Proofing Medicines initiative, a new pan-European, multistakeholder programme of high-level events and reports to explore the impact of cutting-edge scientific and health technology innovations on medicines regulation.